---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-076352"
form_type: "8-K"
ticker: "AVBP"
cik: "0001868279"
company_name: "ArriVent BioPharma, Inc."
filed_at: "2026-06-22T20:01:26+00:00"
generated_at: "2026-06-22T20:02:30.569727+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# ArriVent BioPharma announces 2026 annual meeting voting results; directors elected, auditor ratified

## Summary
- Stockholders elected James Healy, John Hohneker, and Stuart Lutzker as Class II directors for three-year terms.
- Healy received 18,058,285 votes for; Hohneker 28,043,164; Lutzker 29,495,923; broker non-votes 3,832,858 each.
- Ratification of PricewaterhouseCoopers LLP as auditor for FY 2026 passed with 33,411,773 votes for, 829 against.
- Quorum of 33,418,793 shares (72.07% of eligible) was present at the meeting.

## SEC filing metadata
- accession: 0001104659-26-076352
- form_type: 8-K
- ticker: AVBP
- cik: 0001868279
- company_name: ArriVent BioPharma, Inc.
- filed_at: 2026-06-22T20:01:26+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/0001104659-26-076352-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/tm2618466d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-076352
- JSON: https://secwatch.observer/filing/0001104659-26-076352.json
- Plain text: https://secwatch.observer/filing/0001104659-26-076352.txt

## Key facts
- Shareholder Votes
  ArriVent BioPharma, Inc. shareholders approved Election of Directors at the 2026-06-18 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-18
  source text: 1. Election of Directors Nominee Shares Voted For Shares Voted to Withhold Authority Broker Non-votes James Healy, M.D., Ph.D. 18,058,285 11,527,650 3,832,858 John Hohneker, M.D. 28,043,164 1,542,771 3,832,858 Stuart Lutzker, M.D., Ph.D. 29,495,923 90,012 3,832,858
  evidence_url: https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/0001104659-26-076352-index.htm
- Shareholder Votes
  ArriVent BioPharma, Inc. shareholders approved Auditor Ratification at the 2026-06-18 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-18
  source text: 2. Auditor Ratification Shares Voted For Shares Voted Against Shares Abstaining Broker Non-votes 33,411,773 829 6,191 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/0001104659-26-076352-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.